Will Healthcare And Biotech Resume Market Leadership?

Biotech ETFs XBI and IBB are outperforming so far this year. It’s not too surprising if you use Stage Analysis since we know that bear markets are authors of bull markets, and biotech was one of the worst performing sectors of 2016.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.